Buy Regeneron - Cramer's Lightning Round (12/14/17)

Dec. 15, 2017 7:04 AM ETTMUS, EA, ATVI, TTWO, ACOR, OC, REGN, BA


  • Boeing could reach $400 in 18-24 months.
  • Don't buy Acorda Therapeutics.
  • Wait for Owens Corning to pull back before buying.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, December 14.

Bullish Calls

T-Mobile (TMUS): "CEO John Legere made an acquisition, and frankly, I'm puzzled by it. I like T-Mobile. I did not understand this video acquisition. John, come on this show and explain it to us."

Electronic Arts (EA): It's a good stock but Cramer prefers Take-Two Interactive (TTWO) and Activision Blizzard (ATVI).

Regeneron Pharmaceuticals (REGN): It's doing great things but not getting credit for it. Buy it.

Boeing (BA): Don't sell Boeing as it has $400 target in 18-24 months.

Bearish Calls

Acorda Therapeutics (ACOR): No. There are other high-quality stocks out there.

Owens Corning (OC): It's a good stock but is up 66% in a straight line. Wait for a pullback before buying.


Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up

This article was written by

Mohit is the former Managing Editor for the Breaking News (India team) at Seeking Alpha. Currently working with Benzinga, he was with Seeking Alpha from January 2010 until August 2020. Before joining Seeking Alpha in January 2010, he worked with a start-up equity research firm in the capacity of a Team Leader tracking US company events and results.Born in the U.A.E, he spent most of my growing up years in Dubai. Currently, he resides in Mumbai, India.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.